These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29657216)

  • 1. Colistin-induced myasthenic syndrome in a patient with end-stage renal disease.
    Sengupta P; Biswas S
    Saudi J Kidney Dis Transpl; 2018; 29(2):435-439. PubMed ID: 29657216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ur-Ine Trouble: A Case of Nephrolithiasis in A Patient with End-Stage Renal Disease.
    Hasnie AA; Kahn M; Centor R
    Am J Med; 2021 Nov; 134(11):e553-e554. PubMed ID: 34197788
    [No Abstract]   [Full Text] [Related]  

  • 3. Emphysematous polycystic infection in a patient on peritoneal dialysis.
    Nagaraju SP; Gupta A; Mccormick BB; Khandelwal A
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):837-9. PubMed ID: 24969197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
    Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N
    J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens.
    Yılmaz GR; Baştuğ AT; But A; Yıldız S; Yetkin MA; Kanyılmaz D; Akıncı E; Bodur H
    J Infect Chemother; 2013 Feb; 19(1):57-62. PubMed ID: 22806446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unfamiliar course of a familiar illness: a rare ophthalmic complication of urinary sepsis.
    Wilkinson C; Richfield E; Rosenberg K
    Age Ageing; 2006 Jan; 35(1):89-91. PubMed ID: 16364942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
    Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
    J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity after prolonged (more than four weeks) administration of intravenous colistin.
    Falagas ME; Rizos M; Bliziotis IA; Rellos K; Kasiakou SK; Michalopoulos A
    BMC Infect Dis; 2005 Jan; 5():1. PubMed ID: 15642116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France.
    Caspar Y; Maillet M; Pavese P; Francony G; Brion JP; Mallaret MR; Bonnet R; Robin F; Beyrouthy R; Maurin M
    Emerg Infect Dis; 2017 May; 23(5):874-876. PubMed ID: 28418313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis.
    Durakovic N; Radojcic V; Boban A; Mrsic M; Sertic D; Serventi-Seiwerth R; Nemet D; Labar B
    Intern Med; 2011; 50(9):1009-13. PubMed ID: 21532223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study.
    Matthews PC; Barrett LK; Warren S; Stoesser N; Snelling M; Scarborough M; Jones N
    BMC Infect Dis; 2016 Oct; 16(1):556. PubMed ID: 27729016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin resistance in Klebsiella pneumoniae.
    Ah YM; Kim AJ; Lee JY
    Int J Antimicrob Agents; 2014 Jul; 44(1):8-15. PubMed ID: 24794735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purple urine bag syndrome.
    van Iersel M; Mattijssen V
    Neth J Med; 2009 Sep; 67(8):340-1. PubMed ID: 19767663
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary tract infection caused by carbapenem-resistant K. pneumoniae and P. aeruginosa.
    Olaru ID; Popoiu M; Breuil J; Aramă V; Hristea A
    Rom J Intern Med; 2011; 49(4):289-94. PubMed ID: 22568274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of multi drug resistant endogenous
    Dogra M; Sharma M; Katoch D; Dogra M
    Indian J Ophthalmol; 2018 Apr; 66(4):596-597. PubMed ID: 29582834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
    Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.